People: Lonza Group AG (LZAGF.PK)

LZAGF.PK on OTC Markets Group

17 Apr 2014
Price Change (% chg)

$4.03 (+4.33%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Wilden, Peter 

Brief Biography

Mr. Peter Wilden has been Vice Chairman of the Board of Directors at Lonza Group AG. He was appointed Member of the Board of Directors of the Company in March 2004. He is Chairman of the Audit and Compliance Committee at the Company. Currently, he serves as Executive Vice-President Finance and Chief Financial Officer of Ferring Pharmaceuticals in Lausanne, as well as Member of various scientific research organizations in Germany, the United States and the Netherlands. Prior to that, he served as Member of the Board of Trace Biotech AG, Consultant for Mak Data System, Management Assistant with Krupp MaK Maschinenbau GmbH and Scientific Assistant of the Kiel Institute of World Economics, among others. He holds a Doctorate in Philosophy degree in Business Administration from Christian-Albrechts-Universitaet zu Kiel (University of Kiel) and a degree in Business Administration and Information Technology.

Basic Compensation

Total Annual Compensation, CHF Long-Term Incentive Plans, CHF All Other, CHF Fiscal Year Total, CHF
321,146 -- -- 321,146

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks